June 9 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

GSK in talks to buy cancer biotech Nuvalent for more than $9 billion

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Berlin pulls plug on Franco-German fighter jet

UK FCA seeks High Court injunction against Neil Woodford over new online service

Overview

UK pharmaceutical group GSK GSK.L is in talks to buy cancer drugmaker Nuvalent NUVL.O for more than $9 billion.

AstraZeneca AZN.L said participants in a Phase 2 trial shed 11.8% of their weight after 36 weeks on elecoglipron, a daily GLP-1 pill.

Germany has informed France that it wants to withdraw from plans to develop a joint fighter jet, dealing a potentially fatal blow to Europe's largest defense programme.

The UK financial regulator has started legal proceedings against Neil Woodford, alleging the fund manager is providing unauthorised investment advice through W4.0, his new service offering customers access to his investment strategies.